キラル技術の世界市場

Abstract

This report analyzes the worldwide markets for Chiral Technology in US$ Million. Chiral Technology Enabling Products analyzed are Intermediates, Analytical, and Others. The specific end-use segments discussed are Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 40 companies including many key and niche players worldwide such as Albemarle Corporation, BASF AG, Cambrex Corp., Chiral Quest Inc., Dalco ChromTech AB, Daicel Chemical Industries Ltd., DSM Pharmaceutical Products, DowpharmaSM, Johnson Matthey PLC, Regis Technologies Inc., Shasun Chemicals and Drugs Limited, Solvias, Sigma Aldrich Corp, and Suven Life Sciences Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• Chiral Technology Enabling Products
• Chiral Intermediates
• Analytical Products
• Other Products
• Chiral Technology End-Use Products
• Pharmaceuticals
• Agrochemicals

II. EXECUTIVE SUMMARY

1. Introduction

• An Insight into Chiral Technology
• Techniques Used for Achieving Single-Isomers
• Table 1: World Chiral Technology Market (2002 & 2010): Percentage Breakdown of Revenues by Techniques- Traditional Methods, Asymmetric Methods, and Biological Methods (includes corresponding Graph/Chart)
• Importance and Advancements

2. Global Market Overview

• Outlook and Trends
• Good Tidings for Chiral Technology
• Market Drivers
• Demand for Chiral-based Therapeutic Drugs Augments Growth
• New Legislations Push Chiral Technology Demand
• Key Trends
• Organizations Extend Approaches
• Companies' Association with Universities

3. Chiral Technology - An Overview

• Definitions
• Chiral Technology Enabling Products
• Chiral Intermediates
• Analytical Products
• Other Products
• Chiral Technology End-Use Markets
• Pharmaceuticals
• Agrochemicals
• Description
• Functioning of Chiral Molecules
• Chiral Preparation Process
• Traditional Methods
• Biological Methods
• Asymmetric Methods
• Chiral Separation
• Chromatography - The Widely Used Method for Separation
• How it Works?
• Chiral Mobile Phase Additive (CMPA)
• Chiral Stationary Phase (CSP)
• Chiral Recognition
• Protein Chiral Stationary Phases
• Carbohydrate Columns
• Pirkle Columns
• Crystallization
• Solvent Extraction
• Kinetic Resolution
• Capillary Electrophoresis
• Receptor Based Resolution
• Miscellaneous Separative Techniques
• Chiral Synthesis

4. Chiral Technology - Development vs. Acquisition

• In-House Creation & Development
• Acquisition of Technology
• "Economics" of Chiral Technology

5. Chiral Analysis Products

• Chiral Analytical Chromatography
• Chiral Liquid Chromatography
• Supercritical Fluid Chromatography - Substitute to LC for Enantiomer Separations
• Chiral Gas Chromatography
• Chiral Simulated Moving Bed Chromatography
• Partition Chromatography
• Adsorption Chromatography
• Computer Assisted Resolution
• Chiral Polarimetry
• Other Chiral Analytical Techniques
• Calorimetry
• Differential Scanning Calorimetry (DSC)
• Enzymatic Assay
• Immunoassay
• Isotope Dilution
• Nuclear Magnetic Resonance (NMR)
• X-Ray Crystallography

6. Application Markets

• Pharmaceuticals - The Largest Market
• Changing Face of the Pharmaceutical Industry
• Analysis of Chiral Drugs
• Select Companies Involved in Chiral Technology Market
• Table 2: Single-Enantiomer Drugs Market Worldwide (2006): Sales of Select Leading Brands (In US$ Billion) (includes corresponding Graph/Chart)
• Drugs Built on Chiral Technology
• Analgesics
• Anesthetics
• Anti-Infective Products
• Cardiovascular System (CVS) Products
• Angiotensin-Converting Enzyme (ACE) Inhibitors
• Beta-Blockers
• Calcium Channel Blockers
• Diuretics
• Vasodilators
• Central Nervous System (CNS) Agents
• Anticonvulsants
• Sedatives and Tranquilizers
• Stimulants and Antidepressants
• Oncogenic (Cancer-Treatment) Products
• Biochemicals
• Oligonucleotides
• Oxyacids
• Amino Acids
• Sugars and Other Oligosaccharides
• Vitamins
• Peptides
• Pesticides - A Thriving Market
• Herbicides
• Insecticides
• Fungicides
• Other Products
• Liquid Crystals
• Flavor and Aroma Chemicals

7. Chiral Isomerism

• Organic Chemical Isomerism Types
• Structural Isomerism
• Chain Isomerism
• Position Isomerism
• Functional Group Isomerism
• Stereoisomerism
• Dynamic Isomerism (Tautomerism)
• Patents

8. Regulatory & Environmental Issues

9. Product Introductions

• Degussa Develops Novel Processes to Synthesize (S) CAP
• Regis Technologies, Inc. Launches RegisPack Chiral
• Columns
• Sigma-Aldrich Introduces ChiroSolv(tm) Kits
• Sigma-Aldrich Launches Ascentis Express HPLC Columns
• Evolved Nanomaterial Releases Revolutionary Analytical Chiral Column
• BASF Develops Novel Process to Produce Chiral Intermediates
• Chiral Quest Launches C3 TunePhos

10. Recent Industry Activity

• Cambrex to Buy ProSyntest AS
• Johnson Matthey and X-Zyme Sign Licensing Agreement
• Chiral Quest Starts a New Production Facility
• Chiral Quest Completes Reverse Merger with Surg II
• DSM and IEP Extend Partnership
• Shasun Chemicals Acquires Rhodia Pharma Solutions
• Sigma-Aldrich Corp Acquires Astec
• Solvias Receives License for MeOBIPHEP Catalyst Technology
• Codexis Acquires Juelich Fine Chemicals
• ChiroBlock Exits from Chiral Compounds Business
• Chiral Quest Opens New Facility in China
• Chiral Quest to Supply C3 TunePhos to Phoenix Chemicals
• Lonza and Codexis Sign Agreement for Biocatalysis Process
• DSM Signs Licensing Agreement with Chiral Quest
• Chiral Quest Signs Distribution Agreement with Aldrich Chemical
• BASF and Solvias to Collaborate on Chiral Molecule Development
• Chiral Quest and Avantium Enter into Partnership

11. Focus on Select Players

• Albemarle Corporation (USA)
• BASF AG (Germany)
• Cambrex Corp. (USA)
• Chiral Quest Inc (US)
• Dalco ChromTech AB (Sweden)
• Daicel Chemical Industries Ltd. (Japan)
• DSM Pharmaceutical Products (Netherlands)
• DowpharmaSM (USA)
• Johnson Matthey PLC (UK)
• Regis Technologies Inc (USA)
• Shasun Chemicals and Drugs Limited (India)
• Solvias (Switzerland)
• Sigma Aldrich Corp (USA)
• Suven Life Sciences Ltd. (USA)

12. Global Market Perspective

• Table 3: World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 4: World Long-term Projections for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 5: World 10-Year Perspective for Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 6: World Recent Past, Current & Future Analysis for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 7: World Long-term Projections for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 8: World 10-Year Perspective for Chiral Intermediates by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 9: World Recent Past, Current & Future Analysis for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 10: World Long-term Projections for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• TABLE 11: World 10-Year Perspective for Chiral Analytical Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 12: World Recent Past, Current & Future Analysis for Other Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 13: World Long-term Projections for Other Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 14: World 10-Year Perspective for Other Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 15: World Recent Past, Current & Future Analysis for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 16: World Long-term Projections for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 17: World 10-Year Perspective for Chiral Technology in Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 18: World Recent Past, Current & Future Analysis for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 19: World Long-term Projections for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 20: World 10-Year Perspective for Chiral Technology in Agrochemicals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Overview
  • Product Introductions/Developments
  • Strategic Corporate Developments
  • Select Players
  • Albemarle Corporation
  • Cambrex Corp.
  • Chiral Quest Inc
  • DowpharmaSM
  • Regis Technologies Inc
  • Sigma Aldrich Corp
  • Suven Life Sciences Ltd.
• B. Market Analytics
  • Table 21: US Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 22: US Long-term Projections for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • TABLE 23: US 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 24: US Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 25: US Long-term Projections for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 26: US 10-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2008 & 2012

2. Japan

• A. Market Analysis
  • Outlook
  • Daicel Chemical Industries Ltd - A Major Player
• B. Market Analytics
  • Table 27: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 28: Japanese Long-term Projections for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 29: Japanese 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 30: Japanese Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 31: Japanese Long-term Projections for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 32: Japanese 10-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals and Agrochemicals Markets for Years 2003, 2008 & 2012

3. Europe

• A. Market Analysis
  • Overview
  • Product Introductions
  • Strategic Corporate Developments
  • Select Players
  • BASF AG (Germany)
  • Dalco ChromTech AB (Sweden)
  • DSM Pharmaceutical Products (Netherlands)
  • Johnson Matthey PLC (UK)
  • Solvias (Switzerland)
• B. Market Analytics
  • Table 33: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 34: European Long-term Projections for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 35: European 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 36: European Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 37: European Long-term Projections for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 38: European 10-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2008 & 2012

4. Rest of World

• A. Market Analysis
  • Outlook
  • India
  • Chiral Drugs in Indian Market
  • China-A Hub for Pharmaceutical Manufacturing
  • Strategic Corporate Development
  • Shasun Chemicals and Drugs Limited - A Major Indian Player
• B. Market Analytics
  • Table 39: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 40: Rest of World Long-term Projections for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 41: Rest of World 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 42: Rest of World Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 43: Rest of World Long-term Projections for Chiral Technology by End-Use Segment - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 44: Rest of World 10-Year Perspective for Chiral Technology by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2008 & 2012

ご注意：当報告書はDRM（デジタル著作権管理システム）付PDFとなります。 PDFのダウンロード・閲覧にはAdobe Acrobat Reader Ver. 7.0 が必要となります。ご購入頂いた場合、同Acrobat Reader （ご購入時無償配布）をPCにインストールして頂き、ダウンロードを行ったPC上のみでの閲覧と、1回のプリントアウトが可能となっております。ご不明な点につきましてはお問合せください。